Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor

Anesthesia and Analgesia

Volumn 98, Issue 2, 2004, Pages 318-320

  Dilger, John A ^a   Rho, Edwin H ^a   Que, Florencia G ^a   Sprung, Juraj ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CISATRACURIUM; ENALAPRIL; EPHEDRINE; FELODIPINE; FENTANYL; GLYCOPYRRONIUM BROMIDE; ISOFLURANE; OCTREOTIDE; PROPOFOL; SUXAMETHONIUM;

AGED; ARTICLE; BOLUS INJECTION; BRADYCARDIA; CARCINOID; CASE REPORT; DIARRHEA; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; FLUSHING; GENERAL ANESTHESIA; HEART BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PALPITATION; HEART SURGERY; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 1642541879     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000097170.27056.08     Document Type: Article

References (23)

1. Osadchii OE, Pokrovskii VM. Somatostatin as a regulator of cardiovascular system functions. Usp Fiziol Nauk 1998;29:24-41.
2. Preston E, Courtice GP. Cardiac vagal effects in the toad are attenuated by repetitive vagal stimulation. Neuropeptides 1993;25:193-8.
3. Webb SC, Krikler DM, Hendry WG, et al. Electrophysiological actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia. Br Heart J 1986;56:236-41.
4. Day SM, Gu J, Polak JM, Bloom SR. Somatostatin in thr human heart and comparison with guinea pig and rat heart. Br Heart J 1985;53:153-7.
5. Ghirlanda G, Santarelli P, Uccioli L, et al. Electrophysiologic effects of somatostatin in man. Peptides 1986;7:265-6.
6. Kinney MAO, Warner ME. Anesthesia for patients with carcinoid tumors. In: Faust RJ, ed. Anesthesiology review. 3rd ed. New York: Churchill Livingstone, 2002:506-7.
7. Herrington AM, George KW, Moulds CC. Octreotide-induced bradycardia. Pharmacotherapy 1998;18:413-6.
8. Wilinsky MP, Berndt EM. Octreotide acetate (Sandostatin) induced bradycardia: a case report. Hosp Pharm. 1997;32:1.
9. Physician's Desk Reference. Montvale, NJ: Medical Economics Company, Inc, 2001.
10. Eriksson LS, Brundin T, Soderlund C, Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987;22:919-25.
11. Erbas T, Usman A, Erbas B, et al. Short-term effects of somatostatin analogue (SMS 201-995) on left ventricular function in healthy persons: a scintigraphic study. J Endocrinol Invest 1993;16:857-61.
12. Sabat M, Guarner C, Soriano G, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci 1998;43:2184-9.
13. Chanson P, Timsit J, Masquet C, et al. Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 1990;113:921-5.
14. Thuesen L, Christensen SE, Weeke J, et al. The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin Endocrinol (Oxf) 1989;30:619-25.
15. McCormick PA, Chin J, Greenslade L, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995;21:1255-60.
16. Greco AV, Ghirlanda G, Barone C, et al. Somatostatin in paroxysmal supraventricular and junctional tachycardia. BMJ (Clin Res Ed) 1984;288:28.
17. Zironi G, Rossi C, Siringo S, et al. Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. Liver 1996;16:225-34.
18. Gaudin C, Moreau R, Champigneulle B, et al. Short-term cardiovascular effects of somatostatin in patients with cirrhosis. Liver 1995;15:236-41.
19. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm 1989;8:255-73.
20. Henning RJ, Sawmiller DR. Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res 2001;49:27-37.
21. Wiley JW, Uccioli L, Owyang C, Yamada T. Somatostatin stimulates acetylcholine release in the canine heart. Am J Physiol 1989;257:H483-7.
22. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 1995;16:427-42.
23. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-54.